Literature DB >> 21360526

IL-9 is a Th17-derived cytokine that limits pathogenic activity in organ-specific autoimmune disease.

Geoffrey L Stephens1, Bonnie Swerdlow, Ebony Benjamin, Anthony J Coyle, Alison Humbles, Roland Kolbeck, Michael Fung.   

Abstract

IL-9 is a pleiotropic cytokine with key functions in tolerance and inflammation, and its expression is considered a hallmark of Th2-lineage cells. Here, we report that human and mouse Th17 cells are a significant source of IL-9. The expression of IL-9 by Th17 cells was strictly dependent on the presence of TGF-β and IL-1β, and inhibited by IL-4. IL-9-deficient Th17 cells induced more severe autoimmune gastritis following transfer to nu/nu recipient mice. Th17 cells did not appear to be the target of IL-9 bioactivity as Th17 expansion and differentiation was comparable using IL-9-deficient CD4(+) cells or when IL-9 was neutralized with antibodies in vitro. However, reduced mast cell activity was associated with the increased pathogenicity of IL-9-deficient Th17 cells. Together, these results demonstrate a previously unappreciated role for IL-9 in dampening the pathogenic activities of Th17 cells.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21360526     DOI: 10.1002/eji.201040879

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  23 in total

1.  Notch receptors and Smad3 signaling cooperate in the induction of interleukin-9-producing T cells.

Authors:  Wassim Elyaman; Ribal Bassil; Elizabeth M Bradshaw; William Orent; Youmna Lahoud; Bing Zhu; Freddy Radtke; Hideo Yagita; Samia J Khoury
Journal:  Immunity       Date:  2012-04-12       Impact factor: 31.745

Review 2.  IL-9 and Th9 cells: progress and challenges.

Authors:  Picheng Zhao; Xiang Xiao; Rafik M Ghobrial; Xian C Li
Journal:  Int Immunol       Date:  2013-09-11       Impact factor: 4.823

3.  Nuclear factor of activated T cells 1 (NFAT1)-induced permissive chromatin modification facilitates nuclear factor-κB (NF-κB)-mediated interleukin-9 (IL-9) transactivation.

Authors:  Arijita Jash; Anupama Sahoo; Gi-Cheon Kim; Chang-Suk Chae; Ji-Sun Hwang; Jung-Eun Kim; Sin-Hyeog Im
Journal:  J Biol Chem       Date:  2012-03-15       Impact factor: 5.157

Review 4.  Helicobacter pylori Deregulates T and B Cell Signaling to Trigger Immune Evasion.

Authors:  Victor E Reyes; Alex G Peniche
Journal:  Curr Top Microbiol Immunol       Date:  2019       Impact factor: 4.291

5.  IL-9 Controls Central Nervous System Autoimmunity by Suppressing GM-CSF Production.

Authors:  Satoshi Yoshimura; Rodolfo Thome; Shingo Konno; Elisabeth R Mari; Javad Rasouli; Daniel Hwang; Alexandra Boehm; Yanhua Li; Guang-Xian Zhang; Bogoljub Ciric; Abdolmohamad Rostami
Journal:  J Immunol       Date:  2019-12-18       Impact factor: 5.422

Review 6.  Th9 cells in the pathogenesis of EAE and multiple sclerosis.

Authors:  Wassim Elyaman; Samia J Khoury
Journal:  Semin Immunopathol       Date:  2016-11-14       Impact factor: 9.623

Review 7.  Th17 cell cytokine secretion profile in host defense and autoimmunity.

Authors:  Kristen E Graeber; Nancy J Olsen
Journal:  Inflamm Res       Date:  2011-12-25       Impact factor: 4.575

8.  Th9 cells promote antitumor immune responses in vivo.

Authors:  Yong Lu; Sungyoul Hong; Haiyan Li; Jungsun Park; Bangxing Hong; Lijuan Wang; Yuhuan Zheng; Zhiqiang Liu; Jingda Xu; Jin He; Jing Yang; Jianfei Qian; Qing Yi
Journal:  J Clin Invest       Date:  2012-10-15       Impact factor: 14.808

Review 9.  Th9 cells: differentiation and disease.

Authors:  Mark H Kaplan
Journal:  Immunol Rev       Date:  2013-03       Impact factor: 12.988

10.  Rheumatoid arthritis-associated RBPJ polymorphism alters memory CD4+ T cells.

Authors:  William Orent; Allison R Mchenry; Deepak A Rao; Charles White; Hans-Ulrich Klein; Ribal Bassil; Gyan Srivastava; Joseph M Replogle; Towfique Raj; Michael Frangieh; Maria Cimpean; Nicole Cuerdon; Lori Chibnik; Samia J Khoury; Elizabeth W Karlson; Michael B Brenner; Philip De Jager; Elizabeth M Bradshaw; Wassim Elyaman
Journal:  Hum Mol Genet       Date:  2015-11-24       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.